Aerie's Netarsudil's Safety Questions May Determine Fate At Advisory Committee

 
• By Derrick Gingery

Proposed treatment for elevated intraocular pressure would be first in new rho-associated protein kinase inhibitor class.

Eye
In addition to stand-alone treatment for intraocular pressure, Aerie also wants to combine netarsudil with latanoprost for use in glaucoma.

More from US FDA Performance Tracker

More from Regulatory Trackers